Leading Parkinson’s Researcher Dr. Robert A. Hauser Joins Pharmather as Scientific Advisor Post published:October 29, 2020 Post category:Press Release
Pharmather Files for FDA Orphan Drug Designation for Ketamine in Neuropathic Pain Post published:October 28, 2020 Post category:Press Release
Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals Post published:October 22, 2020 Post category:Press Release
Pharmather Files for FDA Orphan Drug Designation for Ketamine in Parkinson’s Disease Post published:October 20, 2020 Post category:Press Release